Condition: PCOS (Polycystic Ovary Syndrome) · Infertility · Anovulation · Sponsor: GABRIEL MONTEIRO PINHEIRO
This randomized clinical trial aims to compare the efficacy and safety of extended letrozole therapy (5 mg/day for 10 days) versus standard letrozole therapy (5 mg/day for 5 days) for ovulation induction in women with polycystic ovary syndrome (PCOS). A total of 84 women aged 18-40 years will be randomized into two groups. Ovulation will be monitored by transvaginal ultrasound and confirmed with urinary LH testing and/or corpus luteum presence. The primary outcome is ovulation rate, while secondary outcomes include number and size of mature follicles, clinical pregnancy rate, multiple pregnancy rate, miscarriage rate, number of cycles until pregnancy, and incidence of ovarian hyperstimulation syndrome (OHSS).
This description comes directly from the study's public registry record.
Katherine Ann R Miller, Medical student · +55(11) 964098358 · katherinereimao000@gmail.com
Gabriel M Pinheiro, MD · +55(11) 97130-7240 · Drg.monteiro@hotmail.com
Always discuss trial participation with your own doctor first.
| Health Complex Dr Wladimir Arruda | São Paulo, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07159880